Each gram of ointment contains Povidone-Iodine USP 50 mg.
Each 1 ml of solution contains Povidone-Iodine USP 100 mg.

Povidex® contains Povidone-Iodine, which is a stable chemical complex of polyvinylpyrrolidone (PVP) and elemental iodine. It exhibits nonselective, broad-spectrum germicidal action and acts as a bactericide (both gram-positive and gram-negative), fungicide, virucide, sporicide, amebicide, insecticide, and nematocide. Povidex® does not induce resistance in microorganisms.Povidex® is safer and easier to use than classic iodine preparations and has low systemic toxicity. It is non-sensitizing and does not cause pain when applied to wounds or mucous membranes.

As an adjunct to systemic therapy in the following indications:
Primary or secondary topical infections
Infected surgical incisions
Infected decubitus or stasis ulcers, and pyodermas
Secondarily infected dermatoses
Infected traumatic lesions
To prevent microbial contamination in burns, incisions, and other topical lesions
Its use for abrasions, minor cuts, and wounds prevents the development of infections and promotes wound healing

For the treatment of infection: Apply once or twice daily or at dressing changes for a maximum of 14 days.
For the prevention of infection: Apply once or twice a week for as long as necessary. The affected skin should be cleaned and dried before application.

Povidone-Iodine may produce local skin reactions, although it is less irritant than iodine. The application of Povidone-Iodine to large wounds or severe burns may lead to systemic adverse effects such as metabolic acidosis, hypernatremia, and impairment of renal function.

Povidone-Iodine is not recommended for regular use in neonates and is contraindicated in very low birth weight infants (below 1500 grams).

Regular use is contraindicated in patients with thyroid disorders (in particular, nodular colloid goiter, endemic goiter, and Hashimoto's thyroiditis)

Regular use of Povidone-Iodine should be avoided in pregnant and lactating women. Special caution is needed when regular applications are made to broken skin in patients with pre-existing renal insufficiency . Regular use should be avoided in patients on concurrent lithium therapy.

Store at a temperature not exceeding 30°C in a dry place. Protect from light. Do not freeze.
Medicine: Keep out of reach of children
